Table 4.

Baseline PET parameters of discovery cohort (patients treated with antiPD1, n = 40)

PET parameter	Mean	Median	Range	IQR
Tumoral SUV max	20.3	16.6	[2.2, 78.21]	12.12–23.74
SUV mean	6.9	6.1	[1.7, 18.92]	5.33–7.54
MTV (mL)	197.6	60.2	[0.03, 2694]	13.47–212.74
SLR	0.9	0.9	[0.669, 1.364]	0.81–0.97

PET Positron emission tomography; IQR Interquarter range; SUVmax Maximum Standardised Uptake Value; SUVmean Mean Standardised Uptake Value; MTV Metabolic Tumour Volume; SLR Spleen to Liver Ratio